Effects of leuprolide in the treatment of central precocious puberty

Peter A. Lee, John G. Page

Research output: Contribution to journalArticlepeer-review

56 Scopus citations


Leuprolide acetate (d-Leu6 des-Gly-NH210, Pro-ethylamide9), a synthetic nonapeptide analog of naturally occurring gonadotropin releasing hormone, was used to treat 62 children with central precocious puberty. Sex steroid levels (testosterone in boys and estradiol in girls) were suppressed during treatment lasting from 3.5 to 24.9 months. Basal follicle-stimulating hormone values and both luteinizing hormone and follicle-stimulating hormone peak responses to stimulation by luteinizing hormone releasing hormone were also suppressed, atthough basal luteinizing hormone values did not differ. Linear growth rate and the rate of bone age advancement decreased during leuprolide therapy. Side effects were minimal. The long-term safety of this treatment has not yet been established; however, leuprolide appears to be an effective long-term therapy for central precocious puberty.

Original languageEnglish (US)
Pages (from-to)321-324
Number of pages4
JournalThe Journal of Pediatrics
Issue number2
StatePublished - Feb 1989

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Effects of leuprolide in the treatment of central precocious puberty'. Together they form a unique fingerprint.

Cite this